In conclusion, using a Golden Syrian hamster model and Vero E6 cells in vitro, this study demonstrated the potential therapeutic efficacy of hrACE2 protein and hrACE2-Fd fusion protein against COVID-19. The gene discussed is ELP1; the disease is COVID-19.